FARAH JAMES: Open Payments
NPI 1174232813 · STOCKBRIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,354 in 75 payments from 11 companies in 2025. Trend: 2023 $754 · 2024 $857 · 2025 $1,354
Food & beverage: $1,354
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 21 | $295 |
| E.R. Squibb & Sons, L.L.C. | 7 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $165 |
| Janssen Pharmaceuticals, Inc | 12 | $155 |
| Otsuka America Pharmaceutical, Inc. | 7 | $146 |
| Neurocrine BioSciences, Inc. | 5 | $133 |
| Alkermes, Inc. | 6 | $120 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $30 |
Products named: COBENFY, CAPLYTA, AUSTEDO XR, UZEDY, INGREZZA, INVEGA SUSTENNA, ARISTADA, REXULTI.
Industry payments across GA — which companies pay providers there.
